Traders Question Slim’s Might as Braskem Idesa Works With Lazard

Braskem-Idesa SAPI bonds, including 2029 notes trading at 70 cents on the dollar, have plunged as investors price in a reduced likelihood of a bailout from Carlos Slim. This decline follows the company's engagement of Lazard and other advisors to review its capital structure, alongside credit downgrades by Fitch and S&P deeper into junk territory, signaling an increasing probability of debt restructuring.

Analysis

Braskem-Idesa SAPI's debt is experiencing a significant sell-off within emerging markets, reflecting a sharp deterioration in investor confidence. The company's 2029 notes have plummeted to 70 cents on the dollar, a direct consequence of the market pricing in a diminished likelihood of a financial rescue from key stakeholder Carlos Slim. This sentiment shift has been accelerated by the company's own actions; it has retained Lazard Inc. and prominent legal advisors to conduct a comprehensive review of its capital structure and liquidity. This move is widely interpreted as a precursor to a potential debt restructuring. The negative outlook is further solidified by recent credit rating downgrades from both Fitch and S&P Global Ratings, which have pushed the company's score deeper into junk territory, formally acknowledging the heightened risk of default or restructuring.

Key Decisions for Investors

• Current holders of Braskem-Idesa bonds should reassess their positions, as the 70-cent price level and the hiring of restructuring advisor Lazard signal that a formal debt restructuring process is increasingly probable.
• Investors with a high-risk tolerance, particularly those specializing in distressed debt, could evaluate the 2029 notes as a potential opportunity, but must conduct deep due diligence on potential recovery values in a restructuring scenario.
• Monitor for potential contagion risk to related entities, including shareholder Braskem S.A. (BAK), as the financial distress of the joint venture could negatively impact its parent's credit profile and equity valuation.